Ruxolitinib for myelofibrosis

The aim of the present study was to assess the beneficial and harmful effects of ruxolitinib in patients with myelofibrosis (MF). The Cochrane databases, PubMed and Embase were searched for studies published up to October 2012. Randomised controlled trials assessing ruxolitinib versus a placebo or t...

Descripción completa

Detalles Bibliográficos
Autores principales: GU, LIAN, SU, LI, CHEN, QING, XIE, JUANJUAN, WU, GUANGLIANG, YAN, YAN, LIANG, BAOYUN, TAN, JINJING, TANG, NONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570263/
https://www.ncbi.nlm.nih.gov/pubmed/23408184
http://dx.doi.org/10.3892/etm.2013.886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570263/
https://www.ncbi.nlm.nih.gov/pubmed/23408184
http://dx.doi.org/10.3892/etm.2013.886

Ejemplares similares